PKG for the management of advance Parkinson’s Disease
Objective: Is PKG an effective way of monitoring advanced PD patients? Is it cost effective? Can PKG be used to review and manage patients virtually? Can PKG…Efficacy of the ankle bracelet-laser to improve gait in Parkinson disease (PD).
Objective: To assess the efficacy of the ankle bracelet-laser in improving gait parameters and functional performance in Parkinson patients with freezing of gait (FOG) Background:…Comparison of pre – and post – clinical outcomes after COVID-19 lockdown in people with Parkinson’s in Portugal
Objective: We compare several pre- and post-clinical outcomes to assess the effects in a group of Portuguese people with PD. Background: Government-mandated restrictions due to…Movement Disorder Fellowships: Assessment and Recruitment Strategies to Meet Clinical Needs
Objective: 1. Identify factors leading to lower number of residents interested in movement disorders fellowship. 2. Propose strategies to increase recruitment. Background: The prevalence of…Characteristics and outcomes of Parkinson’s disease individuals hospitalized with COVID-19 in a New York City hospital system
Objective: To determine the clinical characteristics and outcomes in hospitalized individuals with Parkinson's disease (PD) infected with COVID-19 Background: The COVID-19 pandemic has caused worse…Evaluation of Care delivery model for integrated care and self-management for people with Parkinson’s disease with Deep Brain Stimulation
Objective: To evaluate the implementation and impact potential of a pragmatic network for PD care, the Integrated Parkinson Care Network (IPCN) for patients with chronic…Tele and video consultations of patients with parkinsonism in the Brazilian public health system – a real life feasibility study
Objective: To evaluate the feasibility and identify obstacles in conducting teleconsultations for patients with parkinsonism in the Brazilian public health system Background: Patients with parkinsonism…Phase 1/2 Open-label Dose Evaluation Study of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease: Efficacy, Safety, and Tolerability Data from the Second Cohort at 6 Months
Objective: Results from cohort 2 in the Phase 1/2 SUNRISE-PD study (NCT03720418) at 6 months (6M) post administration of AXO-Lenti-PD (ALPD) gene therapy are presented.…Cinpanemab in Parkinson’s Disease: Imaging and Fluid Biomarker Results from the Phase 2 SPARK Study
Objective: To evaluate the effects of cinpanemab on biomarkers in participants with Parkinson’s disease (PD). Background: SPARK (NCT03318523) was designed to evaluate the safety, pharmacokinetics,…The Hauser Diary knowledge test as a tool to improve Rater Training Programs in Parkinson’s disease clinical trials
Objective: To identify the areas with specific training needs for Rater Training Programs (RTP) on the Hauser Diary in Parkinson’s disease (PD) clinical trials Background:…
- « Previous Page
- 1
- …
- 282
- 283
- 284
- 285
- 286
- …
- 338
- Next Page »